NCT04243434 2020-04-16PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant PatientsAcrotech Biopharma Inc.Phase 1 Unknown56 enrolled